Quelques publications de l’équipe
Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas.
Alentorn A, Dehais C, Ducray F, Carpentier C, Mokhtari K, Figarella-Branger D, Chinot O, Cohen-Moyal E, Ramirez C, Loiseau H, Elouahdani-Hamdi S, Beauchesne P, Langlois O, Desenclos C, Guillamo JS, Dam-Hieu P, Ghiringhelli F, Colin P, Godard J, Parker F, Dhermain F, Carpentier AF, Frenel JS, Menei P, Bauchet L, Faillot T, Fesneau M, Fontaine D, Motuo-Fotso MJ, Vauleon E, Gaultier C, Le Guerinel C, Gueye EM, Noel G, Desse N, Durando X, Barrascout E, Wager M, Ricard D, Carpiuc I, Delattre JY, Idbaih A; POLA Network.
Neurology. 2015 Oct 13;85(15):1325-31.
Wager M, Rigoard P, Bataille B, Guenot C, Supiot A, Blanc JL, Stal V, Pluchon C, Bouyer C, Gil R, Du Boisgueheneuc F.
Br J Neurosurg. 2015 Dec;29(6):829-35.
Retrait de consentement et chirurgie éveillée: illustration et enjeux éthiques.
Wager M, Du Boisgueheneuc F, Bouyer C, Pluchon C, Stal V, Gil R.
Can J Neurol Sci. 2014 Sep;41(5):590-6. doi: 10.1017/cjn.2014.26. French.
Balbous A, Renoux B, Cortes U, Milin S, Guilloteau K, Legigan T, Rivet P, Boissonnade O, Martin S, Tripiana C, Wager M, Bensadoun RJ, Papot S, Karayan-Tapon L.
Mol Cancer Ther. 2014 Sep;13(9):2159-69.
Lack of GOPC-ROS1 (FIG-ROS1) rearrangement in adult human gliomas.
Karayan-Tapon L, Cortes U, Rivet P, Jermidi C, Vassal G, Wager M, Taillandier L.
Eur J Cancer. 2014 Sep;50(13):2364-6.
A mesenchymal glioma stem cell profile is related to clinical outcome.
Balbous A, Cortes U, Guilloteau K, Villalva C, Flamant S, Gaillard A, Milin S, Wager M, Sorel N, Guilhot J, Bennaceur-Griscelli A, Turhan A, Chomel JC, Karayan-Tapon L.
Oncogenesis. 2014 Mar 17;3:e91.
Zouaoui S, Darlix A, Fabbro-Peray P, Mathieu-Daudé H, Rigau V, Fabbro M, Bessaoud F, Taillandier L, Ducray F, Bauchet F, Wager M, Faillot T, Capelle L, Loiseau H, Kerr C, Menei P, Duffau H, Figarella-Branger D, Chinot O, Trétarre B, Bauchet L.
Neurosurg Rev. 2014 Jul;37(3):415-23; discussion 423-4.
EGFR, KRAS, BRAF, and HER-2 molecular status in brain metastases from 77 NSCLC patients.
Villalva C, Duranton-Tanneur V, Guilloteau K, Burel-Vandenbos F, Wager M, Doyen J, Levillain PM, Fontaine D, Blons H, Pedeutour F, Karayan-Tapon L.
Cancer Med. 2013 Jun;2(3):296-304.
Beez T, Boge K, Wager M, Whittle I, Fontaine D, Spena G, Braun S, Szelényi A, Bello L, Duffau H, Sabel M; European Low Grade Glioma Network.
Acta Neurochir (Wien). 2013 Jul;155(7):1301-8.
Wager M, Du Boisgueheneuc F, Pluchon C, Bouyer C, Stal V, Bataille B, Guillevin CM, Gil R.
Neurosurgery. 2013 Jun;72(2 Suppl Operative):ons169-80; discussion ons180-1. doi:
Villalva C, Cortes U, Wager M, Tourani JM, Rivet P, Marquant C, Martin S, Turhan AG, Karayan-Tapon L.
Int J Mol Sci. 2012;13(6):6983-94
Quillien V, Lavenu A, Karayan-Tapon L, Carpentier C, Labussière M, Lesimple T, Chinot O, Wager M, Honnorat J, Saikali S, Fina F, Sanson M, Figarella-Branger D.
Cancer. 2012 Sep 1;118(17):4201-11.